ACAD
41.2
+1.01
+2.51%
AEMD
8.68
-0.06
-0.69%
APRI
1.67
+0.03
+1.83%
ARNA
3.925
-0.06
-1.506%
ATEC
1.35
-0.01
-0.74%
CNAT
5.45
-0.01
-0.18%
CRXM
0.502
+0.012
+2.4694%
CYTX
0.661
-0.071
-9.6735%
DXCM
71.72
+0.45
+0.63%
GNMK
9.17
-0.2
-2.13%
HALO
17.35
-0.33
-1.87%
ILMN
206.08
-2.54
-1.22%
INNV
0.152
0.00
-0.0656%
INO
8.41
-0.17
-1.98%
ISCO
0.05
0.00
0.00%
ISIS
67.32
+0.61
+0.91%
LGND
88.11
-0.04
-0.05%
LPTN
0.285
-0.006
-2.0962%
MBVX
2.32
+0.06
+2.65%
MEIP
1.9
+0.01
+0.53%
MNOV
3.95
0.00
0.00%
MRTX
36.66
+0.48
+1.33%
MSTX
0.54
0.00
0.00%
NBIX
43.86
+1.1
+2.57%
NUVA
50.55
+0.93
+1.87%
ONCS
7.95
+0.35
+4.61%
ONVO
5.01
+0.05
+1.01%
OREX
4.9
-0.02
-0.41%
OTIC
24.52
+0.19
+0.78%
QDEL
21.67
-0.57
-2.56%
RCPT
164.89
+0.06
+0.04%
RGLS
14.12
+0.54
+3.98%
RMD
58.82
+0.17
+0.29%
SCIE
0.021
+0.004
+20.000%
SPHS
1.07
-0.04
-3.60%
SRNE
13.79
-0.01
-0.07%
TROV
10.96
-0.04
-0.36%
VICL
0.95
-0.005
-0.5131%
VOLC
17.99
0.00
0.00%
ZGNX
1.7
+0.21
+14.09%
ACAD
41.2
+1.01
+2.51%
AEMD
8.68
-0.06
-0.69%
APRI
1.67
+0.03
+1.83%
ARNA
3.925
-0.06
-1.506%
ATEC
1.35
-0.01
-0.74%
CNAT
5.45
-0.01
-0.18%
CRXM
0.502
+0.012
+2.4694%
CYTX
0.661
-0.071
-9.6735%
DXCM
71.72
+0.45
+0.63%
GNMK
9.17
-0.2
-2.13%
HALO
17.35
-0.33
-1.87%
ILMN
206.08
-2.54
-1.22%
INNV
0.152
0.00
-0.0656%
INO
8.41
-0.17
-1.98%
ISCO
0.05
0.00
0.00%
ISIS
67.32
+0.61
+0.91%
LGND
88.11
-0.04
-0.05%
LPTN
0.285
-0.006
-2.0962%
MBVX
2.32
+0.06
+2.65%
MEIP
1.9
+0.01
+0.53%
MNOV
3.95
0.00
0.00%
MRTX
36.66
+0.48
+1.33%
MSTX
0.54
0.00
0.00%
NBIX
43.86
+1.1
+2.57%
NUVA
50.55
+0.93
+1.87%
ONCS
7.95
+0.35
+4.61%
ONVO
5.01
+0.05
+1.01%
OREX
4.9
-0.02
-0.41%
OTIC
24.52
+0.19
+0.78%
QDEL
21.67
-0.57
-2.56%
RCPT
164.89
+0.06
+0.04%
RGLS
14.12
+0.54
+3.98%
RMD
58.82
+0.17
+0.29%
SCIE
0.021
+0.004
+20.000%
SPHS
1.07
-0.04
-3.60%
SRNE
13.79
-0.01
-0.07%
TROV
10.96
-0.04
-0.36%
VICL
0.95
-0.005
-0.5131%
VOLC
17.99
0.00
0.00%
ZGNX
1.7
+0.21
+14.09%
Home » Archive by Category

Drug Discovery

San Diego’s Antibody-Drug Conjugate Research Highlighted at #WorldADC Meeting in October

November 24, 2014 – 8:11 am
WorldADC

San Diego was host to the World Antibody Drug Conjugate (ADC) Meeting and Awards October 26-29th 2014. ADCs are an exciting new class of oncology therapeutics utilizing monoclonal antibodies conjugated to cytotoxic drugs, resulting in …

SDBN August 21st 2012 Event At The Sanford Consortium For Regenerative Medicine

August 3, 2012 – 12:41 pm

The Sanford Consortium for Regenerative Medicine is a stem cell research facility representing a collaboration between five of San Diego’s finest research institutions: Sanford-Burnham Medical Research Institute, The Salk Institute, The Scripps Research Institute and …

SDBN June 25th Event With Lilly: Open Innovation Drug Discovery

June 4, 2012 – 1:48 am

San Diego biotech has grown thanks to a collaborative spirit which is sometimes manifested in the acquisition and joining of companies towards a common goal. Lilly’s presence here is indicative of this type of growth, …

San Diego’s Biotechnology Companies: Who’s Taking Off?

March 8, 2012 – 9:13 am

Here at SDBN we’ve been updating our directory of 400+ San Diego biotech companies.  We were surprised to find close to 40 companies removed from the local scene – due to acquisition or shut down.  …

SDBN March 26th 2012 Event with Organovo

March 6, 2012 – 1:59 pm

Organovo is an exciting San Diego biotech company with technology to create human tissue through a technique called 3D bioprinting. The tissue can be used for drug discovery and development, and the company has been …

Focus on San Diego: Life Science Conferences Spring 2012

January 31, 2012 – 11:56 am

This spring San Diego downtown will be buzzing with scientific discussions as our city hosts a number of major scientific symposia.  We are excited to attend and soak in all the science that will be …

Virtual Biotech Part 1: What We Learned About Effectively Outsourcing a Drug Discovery Program

July 28, 2011 – 12:04 pm

The first in our Virtual Biotech series, our July 19th event was a success.  Thanks to our participants – some of San Diego’s leading virtual drug discovery scientists and CROs – for sharing their valuable …

SDBN July 19th Event: Virtual Biotech Part 1: How to Effectively Outsource a Drug Discovery Program

July 1, 2011 – 3:47 pm

Changes in the drug discovery landscape have presented many tough challenges for our region, including downsizing for larger companies and a dearth of VC funding for startups. With these challenges come opportunities, however, because drug …

SDBN June 21st Event Featuring aTyr Pharma

May 27, 2011 – 9:58 am

The San Diego Biotechnology Network’s June 21st event will feature aTyr Pharma, with Board Member and CEO Jeffry Watkins (Bio) giving a talk titled “Innovation: Where is our Biology?” aTyr is developing therapeutics based on …

SDBN April 19th 2011 Event Featuring Celgene

March 22, 2011 – 6:15 pm

Through research, acquisitions, and mergers, Celgene has built a robust product portfolio and pipeline in hematology and oncology. This accomplishment is quite a feat in today’s environment, with pharma pipelines dwindling, and they are one …